Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

JAFKX vs. XLV: which is better?

Bottom line

JAFKX vs XLV: the short answer

JAFKX (Health Sciences Trust) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both mutual funds.

But JAFKX is far broader, holding 173 positions to 65 for XLV, so beyond the top names it adds exposure XLV doesn't have.

XLV is cheaper at 0.08% vs 1.24% — a difference of $116 a year per $10,000 invested.

Over five years, XLV returned +8.1% a year vs +3.9% for JAFKX.

Updated Nov 19, 2026

JAFKX vs XLV side by side

JAFKXXLV
TypeMutual fundETF
Fund familyJohn HancockSPDR (State Street)
CategoryHealth Care SectorHealth Care Sector
Expense ratio1.24%0.08%
Annual cost per $10k$124$8
10-yr cost on $10k (prospectus)$1,510$103
Max front load—None
12b-1 fee0.25%0.02%
1-yr return+19.2%+14.5%
5-yr return (annualized)+3.9%+8.1%
10-yr return (annualized)+8.5%+9.8%
Best quarter—+14.5%
Worst quarter—−12.7%
Net assets (fund)$251.3M$40.6B
Number of holdings17365
Portfolio turnover68%2%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

17 of JAFKX's top 25 holdings also appear in XLV's top 25.

Shared top holdings
HoldingJAFKXXLV
Eli Lilly and Company14.30%16.51%
Johnson and Johnson6.33%10.64%
UnitedHealth Group Incorporated5.95%6.57%
AbbVie Inc.5.28%7.74%
Merck and Co. Inc.4.21%5.52%
Gilead Sciences Inc.2.95%2.73%
Thermo Fisher Scientific Inc.2.67%3.24%
Vertex Pharmaceuticals Incorporated2.38%2.19%
Bristol-Myers Squibb Company2.22%2.05%
Abbott Laboratories2.00%2.75%
Intuitive Surgical Inc.1.98%2.45%
Amgen Inc.1.90%3.40%
Stryker Corporation1.87%1.89%
Elevance Health Inc.1.63%1.46%
Danaher Corporation1.51%2.09%

Source: SEC Form N-PORT

JAFKX top 10

  1. Eli Lilly and Company — 14.30%
  2. Johnson and Johnson — 6.33%
  3. UnitedHealth Group Incorporated — 5.95%
  4. AbbVie Inc. — 5.28%
  5. Merck and Co. Inc. — 4.21%
  6. Gilead Sciences Inc. — 2.95%
  7. Thermo Fisher Scientific Inc. — 2.67%
  8. Vertex Pharmaceuticals Incorporated — 2.38%
  9. Bristol-Myers Squibb Company — 2.22%
  10. Abbott Laboratories — 2.00%

XLV top 10

  1. Eli Lilly & Co — 16.51%
  2. Johnson & Johnson — 10.64%
  3. AbbVie Inc — 7.74%
  4. UnitedHealth Group Inc — 6.57%
  5. Merck & Co Inc — 5.52%
  6. Amgen Inc — 3.40%
  7. Thermo Fisher Scientific Inc — 3.24%
  8. Abbott Laboratories — 2.75%
  9. Gilead Sciences Inc — 2.73%
  10. Intuitive Surgical Inc — 2.45%

FAQ

What is the difference between JAFKX and XLV?
JAFKX (Health Sciences Trust) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both mutual funds. But JAFKX is far broader, holding 173 positions to 65 for XLV, so beyond the top names it adds exposure XLV doesn't have.
Which is cheaper, JAFKX or XLV?
XLV has the lower expense ratio (0.08%).
Should I own both JAFKX and XLV?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.